November 21,2024

IMAX Corporation Reports Third Quarter 2024 Earnings Results

Source By:  BUSINESS WIRE
 October 31,2024

   0        7        0

  • Global entertainment platform delivers Net Income of $14 million (+16% YoY), EPS(1) of 26 cents (+18% YoY), and Cash from Operations of $35 million (+23% YoY)
  • Strong profitability highlighted by Total Adjusted EBITDA(2) of $39 million at a 42% margin; and Adjusted EPS(1)(2) of 35 cents, matching a third quarter record
  • Network growth accelerates as IMAX expects to deliver on high-end of full-year installation guidance, with 49 system installs (+63% YoY) worldwide in Q3
  • Sales activity robust as system signings climb to 119 to-date — outpacing 129 signings for full-year 2023

    i> Strong, diverse year-end slate including “Gladiator II,” “Wicked,” “Moana 2,” and “Mufasa: The Lion King” poised to drive momentum heading into 2025

  • IMAX expects to deliver record of more than $1.2 billion in global box office in 2025 as promising slate solidifies

IMAX Corporation Reports Third Quarter 2024 Earnings Results

Investors:
IMAX Corporation, New York
Jennifer Horsley
212-821-0154
jhorsley@imax.com

Media:
IMAX Corporation, New York
Mark Jafar
212-821-0102
mjafar@imax.com

IMAX Corporation (NYSE: IMAX) today reported solid financial results for the third quarter of 2024, demonstrating the value of its unique global entertainment platform and broad content portfolio.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241030263871/en/

An infographic highlighting IMAX's recent quarter. (Graphic: Business Wire)

An infographic highlighting IMAX's recent quarter. (Graphic: Business Wire)

“IMAX continues to set the table for a new, sustained era of growth with a 2025 and 2026 slate that is as promising as we’ve ever seen,” said Rich Gelfond, CEO of IMAX. “With an exceptional content pipeline, accelerating system installations, and robust sales activity worldwide, we are very well-positioned to execute and capitalize on the opportunity ahead over the next several years.”

“As we look forward, we expect 2025 to be our best year ever at the global box office, with more than $1.2 billion in IMAX grosses worldwide. Our slate next year is highlighted by at least 14 Filmed for IMAX® releases worldwide shot with our cameras, for our screens — a historical indicator of higher indexing for our platform and further proof that filmmakers and audiences prefer the awe-inspiring IMAX Experience ®.”

“Demand for the IMAX platform is strong among our global exhibition partners. We installed nearly 50 new and upgraded systems worldwide in the third quarter — one of our best third quarters for installs ever — and continue to strike agreements in key growth markets, including Australia, France, Japan, and Saudi Arabia.”

“Our third quarter performance further demonstrates our ability to deliver results in any environment, reflecting our flexible, asset-lite business model and diversified content portfolio. With a strong slate ahead, we look forward to fully capitalizing on our model, our strong brand and technology, and our unique global scale to deliver for our shareholders.”

  1. Diluted Net Income Per Share
  2. Non-GAAP Financial Measure. See the discussion at the end of this earnings release for a description of the non-GAAP financial measures used herein, as well as reconciliations to the most comparable GAAP amounts.

Third Quarter Financial Highlights

 

Three Months Ended

 

Nine Months Ended

 

September 30,

 

September 30,

In millions of U.S. Dollars, except per share data

 

2024

 

 

 

2023

 

 

YoY %

Change

 

 

2024

 

 

 

2023

 

 

YoY %

Change

Total Revenue

$

91.5

 

 

$

103.9

 

 

(12

%)

 

$

259.5

 

 

$

288.8

 

 

(10

%)

 

 

 

 

 

 

 

 

 

 

 

 

Gross Margin

$

51.0

 

 

$

62.7

 

 

(19

%)

 

$

141.8

 

 

$

170.7

 

 

(17

%)

Gross Margin (%)

 

55.8

%

 

 

60.4

%

 

 

 

 

54.6

%

 

 

59.1

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Adjusted EBITDA(1)(2)

$

38.7

 

 

$

50.5

 

 

(23

%)

 

$

101.7

 

 

$

118.8

 

 

(14

%)

Total Adjusted EBITDA Margin (%)(1)(2)

 

42.3

%

 

 

48.6

%

 

 

 

 

39.2

%

 

 

41.1

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Income(3)

$

13.9

 

 

$

12.0

 

 

16

%

 

$

20.8

 

 

$

22.8

 

 

(9

%)

Diluted Net Income Per Share(3)

$

0.26

 

 

$

0.22

 

 

18

%

 

$

0.39

 

 

$

0.41

 

 

(5

%)

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted Net Income(1)(3)

$

18.9

 

 

$

19.4

 

 

(3

%)

 

$

36.5

 

 

$

42.8

 

 

(15

%)

Adjusted Earnings Per Share(1)(3)

$

0.35

 

 

$

0.35

 

 

%

 

$

0.68

 

 

$

0.77

 

 

(12

%)

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding (in millions):

 

 

 

 

 

 

 

 

 

 

 

Basic

 

52.7

 

 

 

54.6

 

 

(4

%)

 

 

52.6

 

 

 

54.4

 

 

(3

%)

Diluted

 

54.1

 

 

 

55.5

 

 

(3

%)

 

 

53.6

 

 

 

55.3

 

 

(3

%)

 

  1. Non-GAAP Financial Measure. See the discussion at the end of this earnings release for a description of the non-GAAP financial measures used herein, as well as reconciliations to the most comparable GAAP amounts.
  2. Total Adjusted EBITDA is before adjustments for non-controlling interests. Total Adjusted EBITDA per Credit Facility attributable to common shareholders, excluding non-controlling interests, was $35.6 million and $90.5 million for each of the three and nine months ended September 30, 2024 (2023 - $45.1 million and $105.1 million). The Company’s Credit Facility covenant is calculated on a trailing twelve month basis.
  3. Attributable to common shareholders.

Third Quarter Segment Results(1)

 

Content Solutions

 

Technology Products and Services

 

Revenue

 

Gross Margin

 

Gross

Margin %

 

Revenue

 

Gross Margin

 

Gross

Margin %

3Q24

$

30.1

 

 

$

16.4

 

 

55

%

 

$

58.0

 

 

$

32.0

 

 

55

%

3Q23

 

44.2

 

 

 

26.4

 

 

60

%

 

 

56.2

 

 

 

33.8

 

 

60

%

% change

 

(32

%)

 

 

(38

%)

 

 

 

 

3

%

 

 

(5

%)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

YTD24

$

99.2

 

 

$

54.7

 

 

55

%

 

$

152.0

 

 

$

81.3

 

 

54

%

YTD23

 

107.6

 

 

 

64.4

 

 

60

%

 

 

171.8

 

 

 

100.1

 

 

58

%

% change

 

(8

%)

 

 

(15

%)

 

 

 

 

(12

%)

 

 

(19

%)

 

 

 

  1. Please refer to the Company’s Form 10-Q for the period ended September 30, 2024 for additional segment information.

Content Solutions Segment

  • Content Solutions revenues of $30 million decreased 32% year-over-year driven by the mix of content, which included “Oppenheimer” — the Company’s fifth highest grossing title of all time — in the year prior. Despite the decline, the third quarter 2024 was the third highest grossing third quarter in IMAX history

  • Gross margin for Content Solutions of $16 million decreased 38% compared to the third quarter of the prior year period.

Technology Products and Services Segment

  • Technology Products and Services revenues and gross margin increased 3% year-over-year to $58 million and decreased 5% year-over-year to $32 million, respectively, driven by system installation growth that is outpacing the prior year and offset the lower box office related rental revenue.
  • During the third quarter the Company installed 49 systems compared to 30 systems in the third quarter of 2023, an increase of 63% year-over-year. Of those, 20 systems were under sales arrangements, compared to 16 systems in the prior year.
  • Commercial network growth continues with the number of IMAX locations increasing 4% year-over-year to 1,714 systems. The Company ended Q3 2024 with a backlog of 472 IMAX systems.

Operating Cash Flow and Liquidity

Net cash provided by operating activities for year-to-date September 2024 was $59 million compared to $55 million in the prior year period. Third quarter 2024 net cash provided by operating activities was $35 million compared to $29 million in the prior year period with the increase reflecting improvements in working capital.

As of September 30, 2024, the Company’s available liquidity was $413 million. The Company’s liquidity includes cash and cash equivalents of $105 million, $253 million in available borrowing capacity under the Credit Facility, and $56 million in available borrowing capacity under IMAX China’s revolving facilities. Total debt, excluding deferred financing costs, was $280 million as of September 30, 2024.

In 2021, the Company issued $230.0 million of 0.500% Convertible Senior Notes due 2026 (“Convertible Notes”). In connection with the pricing of the Convertible Notes, the Company entered into privately negotiated capped call transactions with an initial cap price of $37.2750 per share of the Company’s common shares.

Share Count and Capital Return

The weighted average basic and diluted shares outstanding in the third quarter of 2024 were 52.7 million and 54.1 million, respectively, compared to 54.6 million and 55.5 million in the third quarter of 2023, a decrease of 3.5% and 2.6%, respectively.

For the nine months ended September 30, 2024, the Company repurchased 1,166,370 common shares at an average price of $13.99 for a total of $16 million, excluding commissions.

The Company is authorized under its share-repurchase program, expiring June 30, 2026 to repurchase up to $400 million of its common shares, of which approximately $151 million remains available.

Supplemental Materials

For more information about the Company’s results, please refer to the IMAX Investor Relations website located at investors.imax.com.

Investor Relations Website and Social Media

On a monthly basis, the Company posts quarter-to-date box office results on the IMAX Investor Relations website located at investors.imax.com. The Company expects to provide such updates within five business days of month-end, although the Company may change this timing without notice.

The Company may post additional information on the Company’s corporate and Investor Relations website which may be material to investors. Accordingly, investors, media and others interested in the Company should monitor the Company’s website in addition to the Company’s press releases, SEC filings and public conference calls and webcasts, for additional information about the Company.

Conference Call

The Company will host a conference call today at 4:30 PM ET to discuss its third quarter 2024 financial results. This call is being webcast and can be accessed at investors.imax.com. To access the call via telephone, interested parties please pre-register here: https://register.vevent.com/register/BId903a31ed4674fefba1f8b3fdf34072c and you will be provided with a dial-in number and unique pin. To avoid delays, we encourage participants to dial into the conference call ten minutes ahead of the scheduled start time. A replay of the call will be available via webcast at investors.imax.com.

About IMAX Corporation

IMAX, an innovator in entertainment technology, combines proprietary software, architecture, and equipment to create experiences that take you beyond the edge of your seat to a world you’ve never imagined. Top filmmakers and studios are utilizing IMAX systems to connect with audiences in extraordinary ways, making IMAX’s network among the most important and successful theatrical distribution platforms for major event films around the globe.

IMAX is headquartered in New York, Toronto, and Los Angeles, with additional offices in London, Dublin, Tokyo, and Shanghai. As of September 30, 2024, there were 1,788 IMAX systems (1,714 commercial multiplexes, 12 commercial destinations, 62 institutional) operating in 89 countries and territories. Shares of IMAX China Holding, Inc., a subsidiary of IMAX Corporation, trade on the Hong Kong Stock Exchange under the stock code “1970”.

IMAX®, IMAX® 3D, Experience It In IMAX®, The IMAX Experience®, DMR®, Filmed For IMAX®, IMAX LIVETM, IMAX Enhanced®, IMAX StreamSmartTM, and SSIMWAVE® are trademarks and trade names of IMAX Corporation or its subsidiaries that are registered or otherwise protected under laws of various jurisdictions. For more information, visit www.imax.com. You can also connect with IMAX on Instagram (www.instagram.com/company/imax), Facebook (www.facebook.com/imax), LinkedIn (www.linkedin.com/company/imax), X (www.twitter.com/imax), and YouTube (www.youtube.com/imaxmovies).

Forward-Looking Statements

This earnings release contains forward looking statements that are based on IMAX management’s assumptions and existing information and involve certain risks and uncertainties which could cause actual results to differ materially from future results expressed or implied by such forward looking statements. These forward-looking statements include, but are not limited to, references to business and technology strategies and measures to implement strategies, competitive strengths, goals, expansion and growth of business, operations and technology, future capital expenditures (including the amount and nature thereof), industry prospects and consumer behavior, plans and references to the future success of IMAX Corporation together with its consolidated subsidiaries (the “Company”) and expectations regarding the Company’s future operating, financial and technological results. These forward-looking statements are based on certain assumptions and analyses made by the Company in light of its experience and its perception of historical trends, current conditions and expected future developments, as well as other factors it believes are appropriate in the circumstances. However, whether actual results and developments will conform with the expectations and predictions of the Company is subject to a number of risks and uncertainties, including, but not limited to, risks associated with investments and operations in foreign jurisdictions and any future international expansion, including those related to economic, political and regulatory policies of local governments and laws and policies of the United States and Canada, as well as geopolitical conflicts; risks related to the Company’s growth and operations in China; the performance of IMAX remastered films and other films released to the IMAX network; the signing of IMAX System agreements; conditions, changes and developments in the commercial exhibition industry; risks related to currency fluctuations; the potential impact of increased competition in the markets within which the Company operates, including competitive actions by other companies; the failure to respond to change and advancements in technology; risks relating to consolidation among commercial exhibitors and studios; risks related to brand extensions and new business initiatives; conditions in the in-home and out-of-home entertainment industries; the opportunities (or lack thereof) that may be presented to and pursued by the Company; risks related to cyber-security and data privacy; risks related to the Company’s inability to protect the Company’s intellectual property; risks associated with the Company’s use of artificial intelligence and exploration of additional use cases of artificial intelligence; risks related to climate change; risks related to weather conditions and natural disasters that may disrupt or harm the Company’s business; risks related to the Company’s indebtedness and compliance with its debt agreements; general economic, market or business conditions; risks related to political, economic and social instability; the failure to convert system backlog into revenue; changes in laws or regulations; any statements of belief and any statements of assumptions underlying any of the foregoing; other factors and risks outlined in the Company’s periodic filings with the SEC; and other factors, many of which are beyond the control of the Company. Consequently, all of the forward-looking statements made in this earnings release are qualified by these cautionary statements, and actual results or anticipated developments by the Company may not be realized, and even if substantially realized, may not have the expected consequences to, or effects on, the Company. These factors, other risks and uncertainties and financial details are discussed in the Company’s most recent Annual Report on Form 10-K. The Company undertakes no obligation to update publicly or otherwise revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Primary Reporting Groups

The Company’s Chief Executive Officer (“CEO”) is its CODM, as such term is defined under U.S. GAAP. The CODM assesses segment performance based on segment revenues and segment gross margins. Selling, general and administrative expenses, research and development costs, the amortization of intangible assets, provision for (reversal of) current expected credit losses, certain write-downs, interest income, interest expense, and income tax (expense) benefit are not allocated to the Company’s segments.

In the first quarter of 2023, the Company revised its internal segment reporting, including the information provided to the CODM to assess segment performance and allocate resources. Accordingly, the Company has two reportable segments:

  1. Content Solutions, which principally includes the digital remastering of films and other content into IMAX formats for distribution to the IMAX network. To a lesser extent, the Content Solutions segment also earns revenue from the distribution of large-format documentary films and exclusive experiences ranging from live performances to interactive events with leading artists and creators, as well as film post-production services.
  2. Technology Products and Services, which includes results from the sale or lease of IMAX Systems, as well as from the maintenance of IMAX Systems. To a lesser extent, the Technology Product and Services segment also earns revenue from certain ancillary theater business activities, including after-market sales of IMAX System parts and 3D glasses.

Transactions between segments are valued at exchange value. Inter-segment profits are eliminated upon consolidation, as well as for the disclosures below.

IMAX Network and Backlog

 

Three Months Ended

 

Nine Months Ended

 

September 30,

 

September 30,

 

2024

 

2023

 

2024

 

2023

System Signings(1):

 

 

 

 

 

 

 

Sales Arrangements

10

 

13

 

40

 

54

Traditional JRSA

6

 

7

 

71

 

40

Total IMAX System Signings

16

 

20

 

111

 

94

 

  1. System signings include new signings of 15 in Q3 2024, 14 in Q3 2023, 42 in the first three quarters of 2024 and 76 in the first three quarters of 2023.

 

 

Three Months Ended

 

Nine Months Ended

 

September 30,

 

September 30,

 

2024

 

2023

 

2024

 

2023

System Installations(1):

 

 

 

 

 

 

 

Sales Arrangements

20

 

16

 

35

 

35

Hybrid JRSA

 

 

1

 

2

Traditional JRSA

29

 

14

 

52

 

22

Total IMAX System Installations

49

 

30

 

88

 

59

 

  1. System installations include new systems installations of 17 in Q3 2024, 18 in Q3 2023, 45 in the first three quarters of 2024 and 39 in the first three quarters of 2023.

 

 

As of September 30,

 

2024

 

2023

System Backlog:

 

 

 

Sales Arrangements

170

 

192

Hybrid JRSA

95

 

107

Traditional JRSA

207

 

187

Total System Backlog

472

 

486

 

 

 

 

 

As of September 30,

 

2024

 

2023

System Network:

 

 

 

Commercial Multiplex Systems

 

 

 

Sales Arrangements

820

 

743

Hybrid JRSA

129

 

137

Traditional JRSA

765

 

771

Total Commercial Multiplex Systems

1,714

 

1,651

Commercial Destination Systems

12

 

12

Institutional Systems

62

 

68

Total System Network

1,788

 

1,731

IMAX CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands of U.S. dollars, except per share amounts)
(Unaudited)

 

Three Months Ended

 

Nine Months Ended

 

September 30,

 

September 30,

 

 

2024

 

 

 

2023

 

 

 

2024

 

 

 

2023

 

Revenues

 

 

 

 

 

 

 

Technology sales

$

26,305

 

 

$

18,273

 

 

$

54,629

 

 

$

65,455

 

Image enhancement and maintenance services

 

46,891

 

 

 

60,250

 

 

 

149,428

 

 

 

154,244

 

Technology rentals

 

16,122

 

 

 

23,008

 

 

 

48,766

 

 

 

62,612

 

Finance income

 

2,134

 

 

 

2,365

 

 

 

6,713

 

 

 

6,510

 

 

 

91,452

 

 

 

103,896

 

 

 

259,536

 

 

 

288,821

 

Costs and expenses applicable to revenues

 

 

 

 

 

 

 

Technology sales

 

10,605

 

 

 

7,948

 

 

 

24,594

 

 

 

28,951

 

Image enhancement and maintenance services

 

23,087

 

 

 

26,646

 

 

 

73,371

 

 

 

69,470

 

Technology rentals

 

6,741

 

 

 

6,587

 

 

 

19,736

 

 

 

19,747

 

 

 

40,433

 

 

 

41,181

 

 

 

117,701

 

 

 

118,168

 

Gross margin

 

51,019

 

 

 

62,715

 

 

 

141,835

 

 

 

170,653

 

Selling, general and administrative expenses

 

31,466

 

 

 

36,282

 

 

 

100,287

 

 

 

109,336

 

Research and development

 

(265

)

 

 

2,771

 

 

 

3,953

 

 

 

7,388

 

Amortization of intangible assets

 

1,544

 

 

 

1,107

 

 

 

4,208

 

 

 

3,328

 

Credit loss (reversal) expense, net

 

(1,137

)

 

 

523

 

 

 

(963

)

 

 

1,589

 

Restructuring and executive transition costs

 

 

 

 

 

 

 

 

 

 

1,353

 

Income from operations

 

19,411

 

 

 

22,032

 

 

 

34,350

 

 

 

47,659

 

Realized and unrealized investment gains

 

32

 

 

 

364

 

 

 

94

 

 

 

436

 

Retirement benefits non-service expense

 

(109

)

 

 

(77

)

 

 

(323

)

 

 

(232

)

Interest income

 

625

 

 

 

738

 

 

 

1,720

 

 

 

1,838

 

Interest expense

 

(2,240

)

 

 

(1,483

)

 

 

(6,467

)

 

 

(5,045

)

Income before taxes

 

17,719

 

 

 

21,574

 

 

 

29,374

 

 

 

44,656

 

Income tax expense

 

(2,376

)

 

 

(6,555

)

 

 

(3,538

)

 

 

(14,901

)

Net income

 

15,343

 

 

 

15,019

 

 

 

25,836

 

 

 

29,755

 

Net income attributable to non-controlling interests

 

(1,447

)

 

 

(3,029

)

 

 

(5,083

)

 

 

(6,960

)

Net income attributable to common shareholders

$

13,896

 

 

$

11,990

 

 

$

20,753

 

 

$

22,795

 

 

 

 

 

 

 

 

 

Net income per share attributable to common shareholders:

 

 

 

 

 

 

 

Basic

$

0.26

 

 

$

0.22

 

 

$

0.39

 

 

$

0.42

 

Diluted

$

0.26

 

 

$

0.22

 

 

$

0.39

 

 

$

0.41

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding (in thousands):

 

 

 

 

 

 

 

Basic

 

52,682

 

 

 

54,618

 

 

 

52,605

 

 

 

54,424

 

Diluted

 

54,089

 

 

 

55,535

 

 

 

53,628

 

 

 

55,261

 

 

 

 

 

 

 

 

 

Additional Disclosure:

 

 

 

 

 

 

 

Depreciation and amortization

$

14,900

 

 

$

19,279

 

 

$

48,902

 

 

$

46,477

 

Amortization of deferred financing costs

$

493

 

 

$

492

 

 

$

1,478

 

 

$

1,742

 

IMAX CORPORATION
CONSOLIDATED BALANCE SHEETS
(In thousands of dollars, except share amounts)
(Unaudited)

 

September 30,

 

December 31,

 

 

2024

 

 

 

2023

 

Assets

 

 

 

Cash and cash equivalents

$

104,504

 

 

$

76,200

 

Accounts receivable, net of allowance for credit losses

 

114,193

 

 

 

136,259

 

Financing receivables, net of allowance for credit losses

 

123,459

 

 

 

127,154

 

Variable consideration receivables, net of allowance for credit losses

 

74,487

 

 

 

64,338

 

Inventories

 

37,612

 

 

 

31,584

 

Prepaid expenses

 

13,310

 

 

 

12,345

 

Film assets, net of accumulated amortization

 

9,127

 

 

 

6,786

 

Property, plant and equipment, net of accumulated depreciation

 

245,106

 

 

 

243,299

 

Other assets

 

22,981

 

 

 

20,879

 

Deferred income tax assets, net of valuation allowance

 

15,687

 

 

 

7,988

 

Goodwill

 

52,815

 

 

 

52,815

 

Other intangible assets, net of accumulated amortization

 

34,279

 

 

 

35,022

 

Total assets

$

847,560

 

 

$

814,669

 

Liabilities

 

 

 

Accounts payable

$

26,018

 

 

$

26,386

 

Accrued and other liabilities

 

111,283

 

 

 

111,013

 

Deferred revenue

 

53,676

 

 

 

67,105

 

Revolving credit facility borrowings, net of unamortized debt issuance costs

 

46,239

 

 

 

22,924

 

Convertible notes and other borrowings, net of unamortized discounts and debt issuance costs

 

230,038

 

 

 

229,131

 

Deferred income tax liabilities

 

12,521

 

 

 

12,521

 

Total liabilities

 

479,775

 

 

 

469,080

 

Commitments, contingencies and guarantees

 

 

 

Non-controlling interests

 

674

 

 

 

658

 

Shareholders’ equity

 

 

 

Capital stock common shares — no par value. Authorized — unlimited number.

52,682,641 issued and outstanding (December 31, 2023 — 53,260,276 issued and outstanding)

 

394,603

 

 

 

389,048

 

Other equity

 

181,911

 

 

 

185,087

 

Statutory surplus reserve

 

3,932

 

 

 

3,932

 

Accumulated deficit

 

(279,993

)

 

 

(292,845

)

Accumulated other comprehensive loss

 

(11,015

)

 

 

(12,081

)

Total shareholders’ equity attributable to common shareholders

 

289,438

 

 

 

273,141

 

Non-controlling interests

 

77,673

 

 

 

71,790

 

Total shareholders’ equity

 

367,111

 

 

 

344,931

 

Total liabilities and shareholders’ equity

$

847,560

 

 

$

814,669

 

IMAX CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands of dollars)
(Unaudited)

 

Nine Months Ended

 

September 30,

 

 

2024

 

 

 

2023

 

Operating Activities

 

 

 

Net income

$

25,836

 

 

$

29,755

 

Adjustments to reconcile net income to cash provided by operating activities:

 

 

 

Depreciation and amortization

 

48,902

 

 

 

46,477

 

Amortization of deferred financing costs

 

1,478

 

 

 

1,742

 

Credit loss (reversal) expense, net

 

(963

)

 

 

1,589

 

Write-downs, including asset impairments

 

3,034

 

 

 

872

 

Deferred income tax benefit

 

(7,339

)

 

 

(3,724

)

Share-based and other non-cash compensation

 

17,261

 

 

 

17,830

 

Unrealized foreign currency exchange (gain) loss

 

(527

)

 

 

52

 

Realized and unrealized investment gain

 

(94

)

 

 

(436

)

Changes in assets and liabilities:

 

 

 

Accounts receivable

 

23,001

 

 

 

(2,392

)

Inventories

 

(6,181

)

 

 

(13,771

)

Film assets

 

(17,892

)

 

 

(14,575

)

Deferred revenue

 

(13,393

)

 

 

(4,670

)

Changes in other operating assets and liabilities

 

(13,771

)

 

 

(4,141

)

Net cash provided by operating activities

 

59,352

 

 

 

54,608

 

Investing Activities

 

 

 

Purchase of property, plant and equipment

 

(3,816

)

 

 

(2,541

)

Investment in equipment for joint revenue sharing arrangements

 

(21,728

)

 

 

(10,705

)

Acquisition of other intangible assets

 

(4,802

)

 

 

(5,418

)

Net cash used in investing activities

 

(30,346

)

 

 

(18,664

)

Financing Activities

 

 

 

Revolving credit facility borrowings

 

55,000

 

 

 

31,032

 

Repayments of revolving credit facility borrowings

 

(32,000

)

 

 

(43,057

)

Repayments of other borrowings

 

(489

)

 

 

 

Proceeds from other borrowings

 

 

 

 

315

 

Repurchase of common shares

 

(18,102

)

 

 

(4,263

)

Taxes withheld and paid on employee stock awards vested

 

(4,978

)

 

 

(6,458

)

Common shares issued - stock options exercised

 

98

 

 

 

 

Principal payment under finance lease obligations

 

(480

)

 

 

(480

)

Dividends paid to non-controlling interests

 

 

 

 

(1,438

)

Net cash used in financing activities

 

(951

)

 

 

(24,349

)

Effects of exchange rate changes on cash

 

249

 

 

 

607

 

Increase in cash and cash equivalents during period

 

28,304

 

 

 

12,202

 

Cash and cash equivalents, beginning of period

 

76,200

 

 

 

97,401

 

Cash and cash equivalents, end of period

$

104,504

 

 

$

109,603

 

Segment Revenue and Gross Margin

 

Three Months Ended

 

Nine Months Ended

 

September 30,

 

September 30,

(In thousands of dollars)

 

2024

 

 

2023

 

 

2024

 

 

2023

Revenue

 

 

 

 

 

 

 

Content Solutions

$

30,129

 

$

44,214

 

$

99,218

 

$

107,605

Technology Products and Services

 

57,971

 

 

56,169

 

 

152,019

 

 

171,813

Sub-total for reportable segments

 

88,100

 

 

100,383

 

 

251,237

 

 

279,418

All Other(1)

 

3,352

 

 

3,513

 

 

8,299

 

 

9,403

Total

$

91,452

 

$

103,896

 

$

259,536

 

$

288,821

 

 

 

 

 

 

 

 

Gross Margin

 

 

 

 

 

 

 

Content Solutions

$

16,449

 

$

26,407

 

$

54,686

 

$

64,397

Technology Products and Services

 

31,964

 

 

33,761

 

 

81,331

 

 

100,066

Sub-total for reportable segments

 

48,413

 

 

60,168

 

 

136,017

 

 

164,463

All Other(1)

 

2,606

 

 

2,547

 

 

5,818

 

 

6,190

Total

$

51,019

 

$

62,715

 

$

141,835

 

$

170,653

 

  1. All Other includes the results from the Company’s streaming and consumer technology business, as well as other ancillary activities.

IMAX CORPORATION
NON-GAAP FINANCIAL MEASURES
(In thousands of U.S. dollars)

In this release, the Company presents adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per basic and diluted share, EBITDA, Adjusted EBITDA per Credit Facility, Adjusted EBITDA margin as supplemental measures of the Company’s performance, which are not recognized under U.S. GAAP. Adjusted net income or loss attributable to common shareholders and adjusted net income or loss attributable to common shareholders per basic and diluted share exclude, where applicable: (i) share-based compensation; (ii) realized and unrealized investment gains or losses; (iii) transaction-related expenses; and (iv) restructuring and executive transition costs, as well as the related tax impact of these adjustments.

The Company believes that these non-GAAP financial measures are important supplemental measures that allow management and users of the Company’s financial statements to view operating trends and analyze controllable operating performance on a comparable basis between periods without the after-tax impact of share-based compensation and certain unusual items included in net income attributable to common shareholders. Although share-based compensation is an important aspect of the Company’s employee and executive compensation packages, it is a non-cash expense and is excluded from certain internal business performance measures.

A reconciliation from net income (loss) attributable to common shareholders and the associated per share amounts to adjusted net income attributable to common shareholders and adjusted net income attributable to common shareholders per diluted share is presented in the table below. Net income (loss) attributable to common shareholders and the associated per share amounts are the most directly comparable GAAP measures because they reflect the earnings relevant to the Company’s shareholders, rather than the earnings attributable to non-controlling interests.

In addition to the non-GAAP financial measures discussed above, management also uses “EBITDA,” as such term is defined in the Credit Agreement, and which is referred to herein as “Adjusted EBITDA per Credit Facility.” As allowed by the Credit Agreement, Adjusted EBITDA per Credit Facility includes adjustments in addition to the exclusion of interest, taxes, depreciation and amortization. Accordingly, this non-GAAP financial measure is presented to allow a more comprehensive analysis of the Company’s operating performance and to provide additional information with respect to the Company’s compliance with its Credit Agreement requirements, when applicable. In addition, the Company believes that Adjusted EBITDA per Credit Facility presents relevant and useful information widely used by analysts, investors and other interested parties in the Company’s industry to evaluate, assess and benchmark the Company’s results.

EBITDA is defined as net income or loss excluding: (i) income tax expense or benefit; (ii) interest expense, net of interest income; (iii) depreciation and amortization, including film asset amortization; and (iv) amortization of deferred financing costs. Adjusted EBITDA per Credit Facility is defined as EBITDA excluding: (i) share-based and other non-cash compensation; (ii) realized and unrealized investment gains or losses; (iii) transaction-related expenses; (iv) restructuring and executive transition costs; and (v) write- downs, net of recoveries, including asset impairments and credit loss expense.

A reconciliation of net income (loss) attributable to common shareholders, which is the most directly comparable GAAP measure, to EBITDA and Adjusted EBITDA per Credit Facility is presented in the table below. Net income (loss) attributable to common shareholders is the most directly comparable GAAP measure because it reflects the earnings relevant to the Company’s shareholders, rather than the earnings attributable to non-controlling interests.

In this release, the Company also presents free cash flow, which is not recognized under U.S. GAAP, as a supplemental measure of the Company’s liquidity. The Company definition of free cash flow deducts only normal recurring capital expenditures, including the Company’s investment in joint revenue sharing arrangements, the purchase of property, plant and equipment and the acquisition of other intangible assets (from the Consolidated Statements of Cash Flows), from net cash provided by or used in operating activities. Management believes that free cash flow is a supplemental measure of the cash flow available to reduce debt, add to cash balances, and fund other financing activities. Free cash flow does not represent residual cash flow available for discretionary expenditures. A reconciliation of cash provided by operating activities to free cash flow is presented below.

These non-GAAP measures may not be comparable to similarly titled amounts reported by other companies. Additionally, the non-GAAP financial measures used by the Company should not be considered as a substitute for, or superior to, the comparable GAAP amounts.

Adjusted EBITDA per Credit Facility

 

Three Months Ended

 

(In thousands of U.S. Dollars)

September 30, 2024

 

September 30, 2023

Revenues

$

91,452

 

 

$

103,896

 

Reported net income

$

15,343

 

 

$

15,019

 

Add (subtract):

 

 

 

Income tax expense

 

2,376

 

 

 

6,555

 

Interest expense, net of interest income

 

1,123

 

 

 

253

 

Depreciation and amortization, including film asset amortization

 

14,900

 

 

 

19,279

 

Amortization of deferred financing costs(1)

 

493

 

 

 

492

 

EBITDA

$

34,235

 

 

$

41,598

 

Share-based and other non-cash compensation

 

5,508

 

 

 

5,297

 

Unrealized investment gains

 

(32

)

 

 

(364

)

Transaction-related expenses

 

 

 

 

3,086

 

Write-downs, including asset impairments and credit loss expense

 

(1,025

)

 

 

921

 

Total Adjusted EBITDA

$

38,686

 

 

$

50,538

 

Total Adjusted EBITDA margin

 

42.3

%

 

 

48.6

%

Less: Non-controlling interest

 

(3,116

)

 

 

(5,455

)

Adjusted EBITDA per Credit Facility - attributable to common shareholders

$

35,570

 

 

$

45,083

 

 

  1. The amortization of deferred financing costs is recorded within Interest Expense in the Condensed Consolidated Statement of Operations.

 

 

Twelve Months Ended

 

(In thousands of U.S. Dollars)

September 30, 2024(1)

 

September 30, 2023(1)

Revenues

$

345,554

 

 

$

386,867

 

Reported net income

$

29,147

 

 

$

33,836

 

Add (subtract):

 

 

 

Income tax expense

 

1,688

 

 

 

16,917

 

Interest expense, net of interest income

 

3,907

 

 

 

2,024

 

Depreciation and amortization, including film asset amortization

 

62,447

 

 

 

60,475

 

Amortization of deferred financing costs(2)

 

1,970

 

 

 

2,454

 

EBITDA

$

99,159

 

 

$

115,706

 

Share-based and other non-cash compensation

 

23,661

 

 

 

25,893

 

Unrealized investment gains

 

(123

)

 

 

(407

)

Transaction-related expenses

 

327

 

 

 

3,408

 

Restructuring and executive transition costs

 

1,593

 

 

 

1,353

 

Write-downs, including asset impairments and credit loss expense

 

2,359

 

 

 

4,328

 

Total Adjusted EBITDA

$

126,976

 

 

$

150,281

 

Total Adjusted EBITDA margin

 

36.7

%

 

 

38.8

%

Less: Non-controlling interest

$

(13,422

)

 

$

(17,363

)

Adjusted EBITDA per Credit Facility - attributable to common shareholders

$

113,554

 

 

$

132,918

 

 

  1. The Senior Secured Net Leverage Ratio is calculated using Adjusted EBITDA per Credit Facility determined on a trailing twelve-month basis.
  2. The amortization of deferred financing costs is recorded within Interest Expense in the Condensed Consolidated Statement of Operations.

 

Adjusted Net Income Attributable to Common Shareholders and Adjusted Net Income Per Share

 

Three Months Ended

September 30, 2024

 

Three Months Ended

September 30, 2023

(In thousands of U.S. Dollars, except per share amounts)

Net Income

 

Per Diluted

Share

 

Net Income

 

Per Diluted

Share

Net income attributable to common shareholders

$

13,896

 

 

$

0.26

 

 

$

11,990

 

 

$

0.22

 

Adjustments(1):

 

 

 

 

 

 

 

Share-based compensation

 

5,332

 

 

 

0.10

 

 

 

5,063

 

 

 

0.09

 

Unrealized investment gains

 

(32

)

 

 

 

 

 

(454

)

 

 

(0.01

)

Transaction-related expenses

 

 

 

 

 

 

 

3,086

 

 

 

0.06

 

Tax impact on items listed above

 

(341

)

 

 

(0.01

)

 

 

(275

)

 

 

 

Adjusted net income(1)

$

18,855

 

 

$

0.35

 

 

$

19,410

 

 

$

0.35

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding — basic

 

 

 

52,682

 

 

 

 

 

54,618

 

Weighted average shares outstanding — diluted

 

 

 

54,089

 

 

 

 

 

55,535

 

  1. Reflects amounts attributable to common shareholders.

     

 

Nine Months Ended September 30,

 

2024

 

 

2023

 

(In thousands of U.S. Dollars, except per share amounts)

Net Income

 

Per Share

 

Net Income

 

Per Share

Net income attributable to common shareholders

$

20,753

 

 

$

0.39

 

 

$

22,795

 

 

$

0.41

 

Adjustments(1):

 

 

 

 

 

 

 

Share-based compensation

 

16,686

 

 

 

0.30

 

 

 

17,110

 

 

 

0.31

 

Unrealized investment gains

 

(94

)

 

 

 

 

 

(526

)

 

 

(0.01

)

Transaction-related expenses

 

 

 

 

 

 

 

3,242

 

 

 

0.06

 

Restructuring and executive transition costs

 

 

 

 

 

 

 

1,353

 

 

 

0.02

 

Tax impact on items listed above

 

(803

)

 

 

(0.01

)

 

 

(1,184

)

 

 

(0.02

)

Adjusted net income(1)

$

36,542

 

 

$

0.68

 

 

$

42,790

 

 

$

0.77

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding — basic

 

 

 

52,605

 

 

 

 

 

54,424

 

Weighted average shares outstanding — diluted

 

 

 

53,628

 

 

 

 

 

55,261

 

 

  1. Reflects amounts attributable to common shareholders.

 

Free Cash Flow

 

Nine Months Ended

 

September 30,

(In thousands of U.S. Dollars)

 

2024

 

 

 

2023

 

Net cash provided by operating activities

$

59,352

 

 

$

54,608

 

Purchase of property, plant and equipment

 

(3,816

)

 

 

(2,541

)

Acquisition of other intangible assets

 

(4,802

)

 

 

(5,418

)

Free cash flow before growth CAPEX(1)

 

50,734

 

 

 

46,649

 

Investment in equipment for joint revenue sharing arrangements

 

(21,728

)

 

 

(10,705

)

Free cash flow

$

29,006

 

 

$

35,944

 

  1. Growth CAPEX is defined as capital expenditures associated with investments in equipment for joint revenue sharing arrangements.

 


About us

Leverage agile frameworks to provide a robust synopsis for high level overviews. Iterative approaches to corporate strategy foster collaborative thinking to further the overall value proposition. Organically grow the holistic world view of disruptive innovation via workplace diversity and empowerment.


CONTACT US



X

Our website uses cookies to provide your browsing experience and relavent informations.Before continuing to use our website, you agree & accept of our Cookie Policy & Privacy